|
Post by orlon on Mar 3, 2017 9:58:39 GMT -5
Who the hell has the 'super secret master plan?'
|
|
|
Post by orlon on Mar 2, 2017 20:18:07 GMT -5
Are we talking about the same 'super secret master plan' that has been kept under wraps for the past two years?
|
|
|
Post by orlon on Mar 2, 2017 10:20:58 GMT -5
750 shares out of nearly one hundred million? Really??
|
|
|
Post by orlon on Feb 23, 2017 11:58:03 GMT -5
Anyone notice the PPS today while being distracted by Charles Mattocks, someone I never heard of until I started reading some posts this am? Stay with the bottom line thought...no sales=no revenue=no increase in PPS. I don't see Mattocks in this equation. Please...stop the hype.
|
|
|
Post by orlon on Feb 22, 2017 14:33:17 GMT -5
Here we go again! Second quarter, third quarter etc 2017, 2018 etc....I reckon ads will air when they air, and FDA WILL DO WHAT THEY DO WHEN THEY DO. All I'm saying is that we've all heard this before, quarter to quarter and year to year. I bet we hear this again next February....
|
|
|
Post by orlon on Feb 21, 2017 16:48:34 GMT -5
It seems to me that keeping the PPS at close to .50c will mean a 1:10 reverse split come March. But I am not very hopefull that short sellers will not attempt to bring the PPS back down to around $1.00. Major pharmas have one reason to destroy the company...profit, and the best way is to do that is short it out of existence. No fingerprints.
|
|
|
Post by orlon on Feb 10, 2017 14:41:04 GMT -5
So sad to see the markets soaring, new highs established, and MNKD languishing in the bowels of the forgotten. I also noticed short interest increased by two million...perhaps those who have lent shares out, received dividends, purchased additional shares, and lent the out as well. I've read posts about the pros and cons of a reverse split, the whys and why nots of TV ads, and how the company is running out of cash...although they keep hiring at the top end of the scale. I think it was the American Steamboat Co that failed to turn a profit, gave themselves bonuses, and hired a few top execs just before they folded their tent leaving stockholders holding the bag. I'm seeing a trend along those lines with MNKD...no sales, no revenue, reverse split on the horizon, hiring Amgen execs, and promising a turnaround any time now. I still keep my fingers crossed for a miracle and remind myself why I bought this stock in the first place. Like the Cubs and Red Sox after long droughts and saying 'maybe next year,' their ship finally came in. I just hope I'm still alive to see MNKD's ship come in.
|
|
|
Post by orlon on Feb 7, 2017 16:30:29 GMT -5
This whole argument becomes meaningless if AFREZZA does not gain traction. No sales=no revenue. Endo's are not backing Afrezza. With a reverse stock split...no sales=no revenue=lower sp below today's, and at some point bankruptcy or sale of the company. It won't be the first time a tremendous product has been sunk by big pharma or short sellers more interested in making money rather seeing the success of a potential life saving therapy. All of these arguments have been made before, and nothing has changed.
|
|
|
Ads
Feb 4, 2017 16:10:55 GMT -5
Post by orlon on Feb 4, 2017 16:10:55 GMT -5
I did not listen to the investor call...did anyone in management speak about the TV ads previous mentioned?
|
|
|
Post by orlon on Jan 31, 2017 15:53:33 GMT -5
I cannot believe we are cheering for .70 cents!
|
|
|
Post by orlon on Jan 30, 2017 12:18:05 GMT -5
They can't fool us! No sir, we're to smart to be fooled😬
|
|
|
Post by orlon on Jan 30, 2017 11:26:39 GMT -5
I expect nothing new.
|
|
|
Post by orlon on Jan 27, 2017 17:08:00 GMT -5
Anyone seen the latest sales figures? Are we winning?
|
|
|
Post by orlon on Jan 26, 2017 14:36:14 GMT -5
I really have nothing to say.
|
|
|
Post by orlon on Jan 25, 2017 16:31:03 GMT -5
Since approval to now, diminished sales which led to decreased revenue, which led to decreased production, which led to decreased confidence, etc. I'll believe the ads when I see them. I've held this stock for quite awhile and still believe in the product...but there are a lot of factors working against Mannkind such as big pharma and industries built on producing delivery of insulin the same way since 1933(?) I can't help but notice the degree of pessimism recently about RS or delisting. I'm afraid I'm one. Put me down for 2/2.
|
|